Sorrento Therapeutics Inc (SRNEQ) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Sorrento Therapeutics Inc   (SRNEQ)
 

Sorrento Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sorrento Therapeutics Inc inventory turnover ratio, the Sorrento Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 1.45 in the second quarter 2023, SRNEQ's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Sorrento Therapeutics Inc in Jun 30 2023 quarter, has decreased to 252 days, compare to 376 days, in the Mar 31 2023 quarter.

Within Healthcare sector 307 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 1436, from total ranking in the first quarter 2023 at 1659.

SRNEQ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sorrento Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRNEQ Inventory Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Inventory Growth -53.37 % -19.72 % 23.07 % 230.96 % 671.13 %
Y / Y Cost of Sales Growth 93.46 % 34.85 % - 521.42 % 546.29 %
Inventory Turnover Ratio (TTM) 1.45 0.97 - 0.98 0.72
SRNEQ's Total Ranking # 1436 # 1659 # 1676 # 1676 # 1676
Average inventory processing period 252 376 - 374 504
Seq. Inventory Growth -14.65 % 13.35 % -44.46 % -13.22 % 46.93 %
Seq. Cost of Sales Growth 69.13 % - - 114.65 % 17.89 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 308
Overall Market # 1436

Inventory Turnover Ratio Statistics
High Average Low
2.31 1.25 0.72
(Dec 31 2019)   (Jun 30 2022)



SRNEQ Company Profile >> Back to SRNEQ Efficiency Comparisons >> Compare SRNEQ Inventory Turnover Ratio to its Competitors

Financial Statements
Sorrento Therapeutics Inc 's Inventories $ 10 Millions Visit SRNEQ's Balance sheet
Sorrento Therapeutics Inc 's Cost of Revenues TTM $ 18 Millions Visit SRNEQ's Income Statement
What are SRNEQ's Sales? Visit SRNEQ's Sales by Segment

Other Inventory Turnover Ratios
Sorrento Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SRNEQ's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SRNEQ's Competitors
Inventory Turnover Ratio for SRNEQ's Suppliers
Inventory Turnover Ratio for SRNEQ's Customers

You may also want to know
SRNEQ's Sales Growth Rates SRNEQ's Pe Price to earnings ratio SRNEQ's Receivables Turnover Ratio SRNEQ's Stock Quote
SRNEQ's Net Income Growth Rates SRNEQ's Ps Price to Sales ratio SRNEQ's Sales per Employee SRNEQ's Asset Turnover Ratio
SRNEQ's Net Margin SRNEQ's Pb Price to Book ratio SRNEQ's Financial Strength Ratios SRNEQ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Sanuwave Health Inc   5.04 $ 5.362  Millions$ 1  Millions
Eargo Inc   5.04 $ 25.455  Millions$ 5  Millions
Exact Sciences Corporation  4.99 $ 608.946  Millions$ 122  Millions
Ufp Technologies Inc   4.91 $ 278.457  Millions$ 57  Millions
Catalyst Pharmaceuticals Inc   4.90 $ 42.851  Millions$ 9  Millions
Abbvie Inc   4.76 $ 17,418.000  Millions$ 3,660  Millions
Adm Tronics Unlimited Inc   4.72 $ 1.918  Millions$ 0  Millions
Precision Optics Corporation Inc   4.70 $ 13.310  Millions$ 3  Millions
Henry Schein Inc   4.64 $ 8,744.000  Millions$ 1,886  Millions
Lifemd Inc   4.44 $ 16.068  Millions$ 4  Millions
Bristol myers Squibb Company  4.43 $ 10,388.000  Millions$ 2,346  Millions
Integrated Biopharma Inc  4.37 $ 46.000  Millions$ 11  Millions
Warby Parker Inc   4.28 $ 282.378  Millions$ 66  Millions
Organogenesis Holdings Inc   4.24 $ 106.453  Millions$ 25  Millions
Harrow Inc   4.23 $ 31.157  Millions$ 7  Millions
Catalent Inc   4.20 $ 3,223.000  Millions$ 768  Millions
T2 Biosystems Inc   4.20 $ 18.679  Millions$ 4  Millions
West Pharmaceutical Services Inc   4.11 $ 1,773.200  Millions$ 431  Millions
Steris Plc  4.10 $ 2,870.535  Millions$ 701  Millions
Neptune Wellness Solutions Inc   4.09 $ 37.567  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  4.08 $ 8,200.000  Millions$ 2,009  Millions
Moderna Inc   4.06 $ 4,541.000  Millions$ 1,118  Millions
Novocure Limited  4.04 $ 122.269  Millions$ 30  Millions
Urogen Pharma Ltd   4.03 $ 8.991  Millions$ 2  Millions
Lftd Partners Inc   4.02 $ 30.589  Millions$ 8  Millions
Escalon Medical Corp   3.95 $ 6.673  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  3.86 $ 68.087  Millions$ 18  Millions
Vericel Corporation  3.76 $ 58.241  Millions$ 15  Millions
Idexx Laboratories Inc  3.74 $ 1,409.005  Millions$ 377  Millions
Envista Holdings Corporation  3.71 $ 1,109.300  Millions$ 299  Millions

Date modified: 2026-08-29T17:19:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.